Rainer Lichtenberger
Plus aucun poste en cours
Profil
Rainer Lichtenberger was the founder and had founded Atriva Therapeutics GmbH in 2015, where he held the title of Chief Executive Officer until 2023.
He also held former positions as Chief Executive Officer at SCT-Spinal Cord Therapeutics GmbH from 2004 to 2011, Managing Director, COO & Chief Financial Officer at CEVEC Pharmaceuticals GmbH, Director-Executive Board at Merckle GmbH from 2002 to 2004, Director-Executive Board at ratiopharm GmbH from 2002 to 2004, and Vice President-Global Marketing at Merck KGaA from 1988 to 2002.
Anciens postes connus de Rainer Lichtenberger
| Sociétés | Poste | Fin |
|---|---|---|
Merckle GmbH
 Merckle GmbH Pharmaceuticals: MajorHealth Technology Merckle GmbH engages in the manufacture of pharmaceutical products. It offers specialty and generic medicines, as well as over-the-counter drugs. The firm also provides management services for the group. The company was founded in 1881 and is headquartered in Blaubeuren, Germany. | Corporate Officer/Principal | - |
Ratiopharm GmbH
 Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Corporate Officer/Principal | - |
| MERCK KGAA | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Directeur Général | - |
SCT-Spinal Cord Therapeutics GmbH
 SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services SCT-Spinal Cord Therapeutics GmbH, a biopharmaceutical company based in Düsseldorf, Germany, is focused on the treatment of traumatic injury to the central nervous system. SCT`s proprietary key technology, the Regeneration Promoting Treatment, is an unique and promising treatment approach aimed at the supression of scar formation. The inhibition of scar formation allows the severed nerves to sprout and/or regenerate which in turn enables the recovery of sensory and motor function. As a first application of the Regeneration Promoting Treatment SCT is focusing on the development of Cordaneurin, a drug for the treatment of acute spinal cord injuries. In pre-clinical studies Cordaneurin has demonstrated its efficacy in the recovery of motor function after spinal cord contusion. | President | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Entreprise privées | 5 |
|---|---|
CEVEC Pharmaceuticals GmbH
 CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Health Technology |
Merckle GmbH
Merckle GmbH Pharmaceuticals: MajorHealth Technology Merckle GmbH engages in the manufacture of pharmaceutical products. It offers specialty and generic medicines, as well as over-the-counter drugs. The firm also provides management services for the group. The company was founded in 1881 and is headquartered in Blaubeuren, Germany. | Health Technology |
Ratiopharm GmbH
Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Health Technology |
SCT-Spinal Cord Therapeutics GmbH
SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services SCT-Spinal Cord Therapeutics GmbH, a biopharmaceutical company based in Düsseldorf, Germany, is focused on the treatment of traumatic injury to the central nervous system. SCT`s proprietary key technology, the Regeneration Promoting Treatment, is an unique and promising treatment approach aimed at the supression of scar formation. The inhibition of scar formation allows the severed nerves to sprout and/or regenerate which in turn enables the recovery of sensory and motor function. As a first application of the Regeneration Promoting Treatment SCT is focusing on the development of Cordaneurin, a drug for the treatment of acute spinal cord injuries. In pre-clinical studies Cordaneurin has demonstrated its efficacy in the recovery of motor function after spinal cord contusion. | Commercial Services |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
